
HealthTech Innovation Days (HTID) – HealthTech For Care
„Glycanostics® is going to be one of 25 most innovative companies that will compete at a pitch competition at the HealthTech Innovation Days (HTID®) in Paris. Please meet our CEO
Early stage, highly accurate and unique cancer diagnostics
„Glycanostics® is going to be one of 25 most innovative companies that will compete at a pitch competition at the HealthTech Innovation Days (HTID®) in Paris. Please meet our CEO
Meet our CEO Eva Kovacova FCCA at the European Angel Investment Summit in Brussels on 10-11 October! Join me at the premier annual conference where angels, entrepreneurs, and change-makers come together to
The network of urologists who provide the Giasay® PROSTATE test is gradually expanding. Today, you can take the highly accurate prostate cancer test at specialist urology clinics in four regional
First Patent Certificate for EP Patent No. 3 775 909 for us! Availabe here.